Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells

HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells

US Patent 9327023 · Granted May 3, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for whole cell analysis2022
Compositions and methods for inhibiting metastasis2020
Microfluidic device and method for detecting rare cells2020
Anti-CXCR1 compositions and methods2020
Isolation and use of solid tumor stem cells2019
Microfluidic device and method for detecting rare cells2018
Compositions and methods of treating cancer2017
Methods of detecting and treating stem-cell containing solid tumors2017
Isolation and use of solid tumor stem cells2016
Method of reducing the number of EMT and MET type breast cancer stem cells2016
Method for treating cancer using an antibody that inhibits notch4 signaling2015
Breast tumor treatment with anti-CXCR1 compositions2015